PPP1R2P9 Antibody

What is PPP1R2P9 and why is it significant for research?

PPP1R2P9, originally classified as a pseudogene, is now recognized as a functional protein that acts as a protein phosphatase inhibitor. It functions by inhibiting the activity of the catalytic subunit of protein phosphatase 1 (PPP1C) . Despite being categorized as a pseudogene, molecular evidence suggests that PPP1R2P9 has retained functional properties throughout evolution. Its significance lies in its role in maintaining genomic stability, cell division processes, and DNA repair mechanisms, making it particularly relevant for cancer research and studies on DNA damage response pathways .

The protein has been detected in human testis and brain tissues, as well as in HepG2 cells, indicating tissue-specific expression patterns that may correlate with specialized functions . Phylogenetic analyses have revealed that PPP1R2P9 appeared before the great mammalian radiation, making it one of the older PPP1R2-related pseudogenes in the evolutionary timeline .

How does PPP1R2P9 differ from its parental gene PPP1R2?

PPP1R2P9 represents one of ten PPP1R2-related pseudogenes (PPP1R2P1-P10) identified in the human genome. While it shares high sequence similarity with the parental PPP1R2 gene, structural analysis reveals several key differences:

• PPP1R2P9 lacks the 5'UTR of the parental gene

• Its 3'UTR is truncated (671 bp in humans)

• It contains a single polyA signal at nucleotide position 1088, suggesting it produces a shorter mRNA transcript

Unlike many pseudogenes that accumulate mutations rendering them non-functional, PPP1R2P9 sequences have not been disrupted in primates, suggesting selective pressure to maintain function . Interestingly, in rodents (mouse and rat), the 3'UTR was deleted in the parental PPP1R2P9, indicating divergent evolutionary paths across mammalian lineages .

What evidence supports the functional role of PPP1R2P9 despite its pseudogene classification?

Multiple lines of evidence indicate PPP1R2P9 is a functional protein:

• Transcriptional data: PPP1R2P9 has extensive transcriptional evidence (1086 GEO, 128 GXA entries) and numerous ESTs detected in testis

• Protein-protein interactions: It has been demonstrated to bind directly to PPP1C

• Enzymatic activity: In heat-stable extracts, it potently inhibits phosphatase activity with an IC50 of 0.2nM

• Evolutionary selection: Signatures of both negative and positive selection have been detected in PPP1R2P9, suggesting evolutionary pressure to maintain function

• Protein detection: PPP1R2P9 has been identified as an interacting partner of PPP1CA by yeast-two hybrid screening in human brain samples

• Western blot validation: Antibodies specific to PPP1R2P9 detect a protein of approximately 35 kDa in human testis and brain tissue samples

PPP1R2P9 Antibody Characteristics and Applications

PPP1R2P9 antibodies have been validated for several key experimental applications:

• Western Blot (WB): Detection of PPP1R2P9 protein in human testis and brain tissue samples, with an observed molecular weight of approximately 35 kDa

• Immunohistochemistry (IHC): Localization of PPP1R2P9 in paraffin-embedded human testis sections

• Immunofluorescence (IF): Detection of PPP1R2P9 in HepG2 cells using fluorescently labeled secondary antibodies

• ELISA: Quantitative detection of PPP1R2P9 protein

Recommended dilutions vary by application:

• WB: 1:200-1:2000

• IHC: 1:20-1:200

• IF: 1:10-1:100

What storage and handling conditions are recommended for PPP1R2P9 antibodies?

To maintain antibody integrity and functionality, the following storage and handling guidelines are recommended:

• Storage temperature: -20°C

• Buffer formulation: PBS with 0.02% sodium azide and 50% glycerol, pH 7.3

• Avoid repeated freeze/thaw cycles to prevent degradation

• Do not aliquot certain formulations to maintain stability

• For long-term storage, maintain antibody in the original manufacturer's vial until use

Proper storage ensures antibody stability and prevents loss of immunoreactivity that could lead to inconsistent experimental results.

What controls should be included when using PPP1R2P9 antibodies in research?

For rigorous experimental design, researchers should incorporate these controls:

• Positive controls:

  • Human testis tissue lysates (Western blot)

  • Human testis tissue sections (IHC)

  • HepG2 cells (IF)

• Negative controls:

  • Secondary antibody only (omit primary antibody)

  • Tissues known not to express PPP1R2P9

  • Blocking peptide competition assay to confirm specificity

• Loading controls for Western blot:

  • Housekeeping proteins (β-actin, GAPDH, β-tubulin)

  • Total protein staining methods (Ponceau S, SYPRO Ruby)

• Validation approaches:

  • siRNA knockdown of PPP1R2P9 to confirm antibody specificity

  • Recombinant protein expression as positive control

  • Comparison with alternative antibody clones when available

How can researchers optimize Western blot protocols for PPP1R2P9 detection?

Based on the published literature and antibody specifications, the following optimizations are recommended for Western blot detection of PPP1R2P9:

• Sample preparation:

  • Use RIPA or similar lysis buffer supplemented with protease inhibitors

  • Heat samples at 95°C for 5 minutes in reducing sample buffer

• Gel electrophoresis:

  • Use 10-12% SDS-PAGE gels for optimal separation

  • Load 20-50 μg of total protein per lane

• Transfer conditions:

  • Transfer to PVDF membrane (preferred over nitrocellulose for this protein)

  • Use semi-dry or wet transfer systems at 100V for 1-2 hours

• Blocking and antibody incubation:

  • Block with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature

  • Dilute primary antibody 1:200-1:2000 in blocking buffer

  • Incubate overnight at 4°C with gentle rocking

  • Use HRP-conjugated secondary antibodies at 1:5000-1:10000 dilution

• Expected results:

  • PPP1R2P9 should be detected at approximately 35 kDa

  • Confirm specificity by comparing with positive control tissues (testis, brain)

What are the critical parameters for successful immunohistochemistry of PPP1R2P9?

For optimal IHC detection of PPP1R2P9 in tissue sections:

• Tissue preparation:

  • Fix tissues in 10% neutral buffered formalin

  • Process and embed in paraffin following standard protocols

  • Section at 4-6 μm thickness

• Antigen retrieval:

  • Heat-induced epitope retrieval in citrate buffer (pH 6.0) or EDTA buffer (pH 9.0)

  • Microwave or pressure cooker treatment for 15-20 minutes

• Blocking and antibody incubation:

  • Block endogenous peroxidase with 3% H₂O₂

  • Block non-specific binding with serum-free protein block

  • Dilute primary antibody 1:20-1:200 in antibody diluent

  • Incubate at 4°C overnight or at room temperature for 1-2 hours

• Detection and visualization:

  • Use polymer-based detection systems for enhanced sensitivity

  • Develop with DAB and counterstain with hematoxylin

  • Dehydrate, clear, and mount with permanent mounting medium

• Expected results:

  • PPP1R2P9 has been validated for detection in human testis and brain tissues

  • Both nuclear and cytoplasmic staining patterns may be observed

How can PPP1R2P9 antibodies be used to study its role in protein phosphatase regulation?

PPP1R2P9 functions as a protein phosphatase inhibitor that regulates PPP1C activity. Researchers can leverage PPP1R2P9 antibodies to investigate this regulatory relationship through several approaches:

• Co-immunoprecipitation (Co-IP):

  • Use PPP1R2P9 antibodies to pull down protein complexes

  • Probe for PPP1C and other potential interacting partners

  • Compare interaction patterns in different cell types and conditions

• Proximity ligation assay (PLA):

  • Visualize and quantify PPP1R2P9-PPP1C interactions at the single-molecule level

  • Determine subcellular localization of interaction complexes

• Phosphatase activity assays:

  • Measure PPP1C activity in the presence and absence of PPP1R2P9

  • Compare with the effect of parental PPP1R2 to identify functional differences

  • Test the effect of PPP1R2P9 on different PPP1 holoenzyme complexes

Recent research has demonstrated that PPP1R2 (the parental gene of PPP1R2P9) stabilizes a subgroup of PP1 holoenzymes, including PP1:RepoMan, promoting the dephosphorylation of their substrates. Mechanistically, PPP1R2 disrupts an inhibitory interaction between the C-terminal tail and catalytic domain of PP1, generating an additional C-terminal interaction site . Similar studies can be designed to determine if PPP1R2P9 acts through comparable mechanisms.

What is known about the role of PPP1R2P9 in reproductive biology, and how can it be studied?

PPP1R2P9 has been detected in human sperm and testis, suggesting a role in reproductive biology . Researchers can investigate this aspect through:

• Expression profiling:

  • Compare PPP1R2P9 expression levels across different stages of spermatogenesis

  • Investigate potential hormonal regulation of PPP1R2P9 expression

• Subcellular localization:

  • Use immunofluorescence to determine the precise localization of PPP1R2P9 in sperm cells

  • Correlate localization with potential functional roles in sperm motility

• Functional studies:

  • Develop PPP1R2P9-specific inhibitors or blocking antibodies

  • Assess the effect on sperm function, including motility parameters and capacitation

  • Compare with the role of the PPP1R2 parental gene in sperm biology

Studies have shown that a PPP1CC2/PPP1R2-like complex is important in the acquisition of sperm motility . Given the detection of PPP1R2P9 in human sperm, similar regulatory functions may exist for this protein, potentially contributing to male fertility regulation.

How can researchers investigate the evolutionary significance of PPP1R2P9 compared to other pseudogenes?

The evolutionary history of PPP1R2P9 presents an interesting case for studying pseudogene functionalization. Researchers can approach this using:

• Comparative genomics:

  • Compare PPP1R2P9 sequences across different mammalian species

  • Identify conserved domains and regulatory elements

  • Map evolutionary changes in relation to functional constraints

• Selective pressure analysis:

  • Calculate nonsynonymous/synonymous substitution ratios (dN/dS)

  • Identify regions under positive or negative selection

  • Compare selection patterns with the parental PPP1R2 gene

• Transcriptional and translational activity:

  • Map PPP1R2P9 expression across different tissues and species

  • Compare with expression patterns of other PPP1R2 pseudogenes

  • Identify species-specific differences in PPP1R2P9 regulation

Phylogenetic analysis suggests that PPP1R2P9 retroposons appeared before the great mammalian radiation, while other PPP1R2 pseudogenes are primate-specific . This early emergence and subsequent conservation suggest a functional importance that preceded the divergence of major mammalian lineages.

How can researchers address non-specific binding when using PPP1R2P9 antibodies?

Non-specific binding is a common challenge when working with antibodies against proteins like PPP1R2P9 that share sequence similarity with related family members. To minimize this issue:

• Optimization strategies:

  • Titrate antibody concentration to find optimal dilution

  • Increase washing stringency (longer washes, higher detergent concentration)

  • Use alternative blocking agents (BSA instead of milk or vice versa)

  • Pre-adsorb antibody with cell/tissue lysates lacking the target

• Validation approaches:

  • Peptide competition assays to confirm specificity

  • Use multiple antibodies targeting different epitopes

  • Compare results with genetic knockdown or knockout models

  • Include appropriate positive and negative control samples

• Background reduction techniques:

  • For IHC: Optimize antigen retrieval, reduce primary antibody incubation time

  • For IF: Use Sudan Black B to reduce autofluorescence

  • For WB: Use gradient gels to better separate proteins of similar molecular weight

What considerations are important when interpreting PPP1R2P9 expression patterns across different tissues?

When analyzing PPP1R2P9 expression across tissues, researchers should consider:

• Tissue-specific regulation:

  • PPP1R2P9 has been detected in testis, brain, and HepG2 cells

  • Expression patterns may vary with developmental stage and physiological conditions

  • Compare with expression of the parental PPP1R2 gene to identify differential regulation

• Potential cross-reactivity:

  • Verify antibody specificity against other PPP1R2 family members

  • Consider using orthogonal methods (qPCR, mass spectrometry) to confirm protein identity

  • Be aware that some peptides may be shared between PPP1R2P9 and related proteins

• Quantification approaches:

  • Normalize expression to appropriate housekeeping genes/proteins

  • Use digital image analysis for IHC/IF quantification

  • Consider using multiplexed detection methods to analyze co-expression with interacting partners

• Functional correlation:

  • Correlate expression levels with relevant physiological or pathological parameters

  • Consider potential post-translational modifications affecting antibody recognition

  • Validate findings with functional assays (e.g., phosphatase activity)

How can researchers differentiate between PPP1R2P9 and other PPP1R2 family members in experimental systems?

Distinguishing PPP1R2P9 from other PPP1R2 family members requires careful experimental design:

• Specific detection approaches:

  • Design PCR primers or probes targeting unique regions of PPP1R2P9 mRNA

  • Use antibodies raised against unique epitopes not shared with other family members

  • Employ mass spectrometry to identify protein-specific peptides

• Functional discrimination:

  • Compare inhibitory potency against PPP1C (IC50 values)

  • Assess protein-protein interaction profiles

  • Evaluate responses to phosphorylation by different kinases

• Cellular localization:

  • Compare subcellular distribution patterns

  • Analyze co-localization with known interaction partners

  • Investigate regulation of localization under different cellular conditions

• Genetic approaches:

  • Use gene-specific siRNA or CRISPR-Cas9 targeting unique regions

  • Complement knockdown studies with re-expression of PPP1R2P9 versus other family members

  • Assess phenotypic rescue to confirm functional specificity